Access EIS investments for August 2022

SyndicateRoom logo
Syndicate Room
6 September 20222 min read

In August, SyndicateRoom added four new startups to the Access EIS portfolio, investing alongside super angels in each case (for more on our super angels, and our co-investment model, see our dedicated page. Find out more about our fund, Access EIS, or read about our new portfolio companies below.


Wild Hydrogen

Wild Hydrogen's carbon negative process converts organic waste into clear hydrogen, while capturing and storing carbon dioxide.

Wild Hydrogen

Our angel partner in the round has a weighted IRR of 32% and has invested in Acacia Pharma, Arecor and Stemnovate.

Total Round: approx. £1,000,000.

Visit website


Syndi

Syndi provides the digital infrastructure to offer personalised and effective digital health support within organisations.

Syndi

Our angel partner in the round has a weighted IRR of 90% and has invested in Nutmeg, Purple Bricks, and Second Home, among others.

Total Round: approx. £440,000.

Stage: Post-revenue.

Visit website


Herd

Herd invites users to predict the outcomes of sports events with their friends via its dedicated mobile application.

Herd

Our angel partner in the round has a flat CAGR of 32% and has invested in Chosen AI, WiseAlpha and Credit Kudos.

Total Round: approx. £490,000.

Visit website


Presto

Presto produces uncomplicated coffee for every kind of coffee drinker, emphasising freshness and quality. It's serious about social and environmental impact, uses 100% recyclable packaging, and has a partnership with the UK's most sustainable roastery to keep carbon emissions low.

Presto

Our angel partner in the round has a flat CAGR of 36% and has invested in Class4Kids, Patch and WeGift.

Total Round: approx. £460,000.

Stage: Post-revenue.

Visit website


Award
What is Access EIS?
Read our fund brochure for everything you need to know about Access, from the specifics of our innovative co-investment model to our fees, and how to invest.

Risk warning: Please click here to read the full risk warning.
Investing in early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Tax relief depends on an individual’s circumstances and may change in the future. In addition, the availability of tax relief depends on the company invested in maintaining its qualifying status. Past performance is not a reliable indicator of future performance. You should not rely on any past performance as a guarantee of future investment performance.
This page has been approved as a financial promotion by Syndicate Room Ltd, which is authorised and regulated by the Financial Conduct Authority (No. 613021).
We use cookies to improve our service. By continuing to use this site you are agreeing to their use. Find out more.
Please provide your email and/or phone number and we'll get back to you as soon as possible.